Type
Internal restructuring
Country
Germany
Region
Hessen; Darmstadt; Frankfurt am Main
Location of affected unit(s)
Frankfurt-Höchst
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

480 jobs
Number of planned job losses
Job loss
Announcement Date
7 March 2017
Employment effect (start)
7 March 2017
Foreseen end date
31 December 2019

Description

On 7 March 2017, the French pharmaceutic producer Sanofi-Aventis announced to cut 480 jobs in Frankfurt-Höchst until 2019. 200 out of these 480 job cuts will be implemented by terminating fixed-term contracts. Affected is the production department where a total of about 5,300 staff members are working at the moment.

The job cuts are part of a restructuring programme. Recently, Sanofi and the German pharmaceutic producer Boehringer Ingelheim swapped business parts. Boehringer Ingelheim took over the business part for veterinary medicines from Sanofri and Sanofri took over the non-prescription market from Boehringer Ingelheim.

Sanofi employs 7,300 staff members at its site in Frankfurt-Höchst.


Sources

  • 8 March 2017: Frankfurter Neue Presse
  • 8 March 2017: finanzen.net

Citation

Eurofound (2017), Sanofi-Aventis, Internal restructuring in Germany, factsheet number 90492, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/90492.